======= DRG1 ======= == Gene Information == * **Official Symbol**: DRG1 * **Official Name**: developmentally regulated GTP binding protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4733|4733]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y295|Q9Y295]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DRG1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DRG1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603952|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Critical regulator of cell growth under specific conditions. Implicated in differentiation and cell cycle arrest. |TGS| |FeoB N| |MMR HSR1| |potassium ion binding| |regulation of mitotic spindle assembly| |regulation of spindle assembly| |positive regulation of microtubule polymerization| |positive regulation of microtubule polymerization or depolymerization| |regulation of mitotic spindle organization| |regulation of spindle organization| |polysome| |regulation of microtubule polymerization| |cytoplasmic translation| |regulation of microtubule polymerization or depolymerization| |positive regulation of protein polymerization| |regulation of mitotic nuclear division| |regulation of microtubule cytoskeleton organization| |regulation of nuclear division| |positive regulation of supramolecular fiber organization| |regulation of organelle assembly| |positive regulation of cytoskeleton organization| |regulation of microtubule-based process| |regulation of protein polymerization| |microtubule binding| |positive regulation of protein complex assembly| |nuclear body| |GTPase activity| |transcription factor binding| |regulation of supramolecular fiber organization| |translation| |GTP binding| |peptide biosynthetic process| |regulation of protein complex assembly| |positive regulation of cellular component biogenesis| |amide biosynthetic process| |peptide metabolic process| |regulation of cytoskeleton organization| |positive regulation of organelle organization| |regulation of mitotic cell cycle| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of cell cycle process| |cellular amide metabolic process| |regulation of cellular component biogenesis| |identical protein binding| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |positive regulation of cellular component organization| |regulation of organelle organization| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.82| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.23| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.85| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.77| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.7| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.7| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.74| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|1.74| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.76| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.81| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|1.84| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.87| |[[:results:exp148|SB202190 10μM R03 exp148]]|1.91| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.94| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.94| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.97| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|2.14| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|2.33| |[[:results:exp275|Citral 75μM R06 exp275]]|2.46| |[[:results:exp135|MS023 7μM R03 exp135]]|2.75| |[[:results:exp116|AICAR 240μM R03 exp116]]|2.79| |[[:results:exp211|AICAR 240μM R05 exp211]]|2.87| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|2.95| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|3.32| ^Gene^Correlation^ |[[:human genes:z:zc3h15|ZC3H15]]|0.487| Global Fraction of Cell Lines Where Essential: 8/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7823 * **Expression level (log2 read counts)**: 5.89 {{:chemogenomics:nalm6 dist.png?nolink |}}